Related Experiment Videos
[Serum noradrenaline and ventricular tachycardia]
J Pella1, D Stopek, E Rybárová
1Ustav experimentálnej medicíny Lekárskej fakulty Univerzity Pavla Jozefa Safárika Kosice.
Vnitrni Lekarstvi
|July 28, 1999
Summary
Sudden cardiac death risk can be assessed by measuring norepinephrine (NE) levels. A significant difference in intracardial versus peripheral NE levels after ventricular stimulation indicates higher risk.
Area of Science:
- Cardiology
- Cardioendocrinology
- Electrophysiology
Context:
- Sudden cardiac death (SCD) is frequently caused by ventricular arrhythmias like ventricular tachycardia (VT).
- Early detection of patients at risk for SCD is crucial for appropriate treatment and mortality reduction.
- The study explores the role of cardioendocrinology in understanding SCD risk.
Purpose:
- To investigate the relationship between serum norepinephrine (NE) levels and the risk of sudden cardiac death.
- To determine if intracardial and peripheral NE levels differ significantly after ventricular stimulation in patients undergoing electrophysiological examination.
Summary:
- Serum norepinephrine levels were measured in the peripheral circulation and right atrium of 17 patients during electrophysiological studies.
- Ventricular tachycardia (VT) was induced in 10 patients. A statistically significant increase in intracardial NE compared to peripheral NE was observed after ventricular stimulation in patients who developed VT.
- No significant difference in NE levels was found in patients without induced VT.
Impact:
- This research suggests that changes in intracardial norepinephrine levels following ventricular stimulation may serve as a biomarker for identifying patients at risk of sudden cardiac death.
- Findings could lead to novel diagnostic approaches in cardioendocrinology for SCD risk stratification.
- Highlights the potential of monitoring neurohormonal responses during electrophysiological procedures for predicting adverse cardiac events.